Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

CLOT STIFFNESS MEASURED BY SEER SONORHEOMETRY AS A MARKER OF POOR PROGNOSIS IN HOSPITALIZED COVID-19 PATIENTS

Francisco José López-Jaime, Sandra Martín-Téllez, Alberto Doblas-Márquez, Ignacio Márquez-Gómez, José María Reguera-Iglesias, Manuel Isidro Muñoz-Pérez, Ihosvany Fernández-Bello, View ORCID ProfileAdrián Montaño
doi: https://doi.org/10.1101/2021.07.13.21260256
Francisco José López-Jaime
*Unidad de Hemostasia y Trombosis, Hospital Universitario Regional de Málaga, IBIMA, Málaga, Spain; (F.J.L.J.); (S.M.-T); (A.D.-M.); (M.I.M.-P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: franlopezjaime@gmail.com sandra.martint@gmail.com albertodoblas93@gmail.com misidro.munoz.sspa@juntadeandalucia.es
Sandra Martín-Téllez
*Unidad de Hemostasia y Trombosis, Hospital Universitario Regional de Málaga, IBIMA, Málaga, Spain; (F.J.L.J.); (S.M.-T); (A.D.-M.); (M.I.M.-P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: franlopezjaime@gmail.com sandra.martint@gmail.com albertodoblas93@gmail.com misidro.munoz.sspa@juntadeandalucia.es
Alberto Doblas-Márquez
*Unidad de Hemostasia y Trombosis, Hospital Universitario Regional de Málaga, IBIMA, Málaga, Spain; (F.J.L.J.); (S.M.-T); (A.D.-M.); (M.I.M.-P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: franlopezjaime@gmail.com sandra.martint@gmail.com albertodoblas93@gmail.com misidro.munoz.sspa@juntadeandalucia.es
Ignacio Márquez-Gómez
†Servicio de Enfermedades Infecciosas, Hospital Universitario Regional de Málaga, Málaga, Spain; (I.M.-G.); (J.M.R.-I)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nacho.marquez83@gmail.com jmreguera99@yahoo.com
José María Reguera-Iglesias
†Servicio de Enfermedades Infecciosas, Hospital Universitario Regional de Málaga, Málaga, Spain; (I.M.-G.); (J.M.R.-I)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nacho.marquez83@gmail.com jmreguera99@yahoo.com
Manuel Isidro Muñoz-Pérez
*Unidad de Hemostasia y Trombosis, Hospital Universitario Regional de Málaga, IBIMA, Málaga, Spain; (F.J.L.J.); (S.M.-T); (A.D.-M.); (M.I.M.-P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: franlopezjaime@gmail.com sandra.martint@gmail.com albertodoblas93@gmail.com misidro.munoz.sspa@juntadeandalucia.es
Ihosvany Fernández-Bello
‡Biopharm, Novo Nordisk, Madrid, Spain; (I.F.-B)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: IHFE@novonordisk.com
Adrián Montaño
*Unidad de Hemostasia y Trombosis, Hospital Universitario Regional de Málaga, IBIMA, Málaga, Spain; (F.J.L.J.); (S.M.-T); (A.D.-M.); (M.I.M.-P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adrián Montaño
  • For correspondence: adrianmo18@gmail.com franlopezjaime@gmail.com sandra.martint@gmail.com albertodoblas93@gmail.com misidro.munoz.sspa@juntadeandalucia.es
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

SUMMARY

Background High incidence of life-threatening thrombotic complications is observed in severely ill COVID-19 patients. D-dimer may help evaluate disease severity and predict outcomes at hospital admission. However, its non-specificity and long analysis times strongly constrain its clinical value. Viscoelastic tests (VET) are widely available rapid point-of-care devices that have been shown to detect a hypercoagulable state (increased clot stiffness and fibrinolysis shutdown) as major contributors of the thrombotic complication in COVID-19. Nevertheless, based on the data obtained so far, definitive conclusions have not been drawn.

Objectives We aim to evaluate the association between VET parameters, standard coagulation tests and inflammation markers assessed in COVID-19 patients at hospital admission with disease severity and outcomes.

Patients/Methods A total of 69 COVID-19 patients requiring hospitalization were included in the study. The pro-inflammatory and pro-thrombotic state was analyzed by a panel of inflammation markers (IL-6, CRP, LDH, ferritin), routine coagulation tests (PT, aPTT, platelet count, fibrinogen, D-dimer) and a SEER sonorheometry VET profile (Quantra® System).

Results Inflammatory markers IL-6, CRP, LDH and ferritin were elevated in a high percentage of patients (73.6%, 89.2%, 57.1% and 52.4%), as were coagulation-related parameters such as fibrinogen (81.4%) and D-dimer levels (66.2%). Quantra® analysis revealed increased clot stiffness (CS) in 34.8%, particularly due to increased fibrinogen contribution (FCS) in 63.7%. Increased clot stability to lysis (CSL) was observed in 32.4%. Age > 65 years, elevated values of fibrinogen, D-dimer, LDH, increased clot stiffness and resistance to clot lysis were significantly associated with worsening disease. The Quantra® FCS parameter showed a particularly high prognostic value in distinguishing patients with severe symptomatology.

Conclusion The global study of hemostasis by the whole blood point-of-care Quantra® VET system may be a powerful tool for identifying poor prognosis in COVID-19 patients at hospital admission. In particular, FCS measured by Quantra® could be established as a plausible prognostic marker to aid the clinical management of COVID-19 patients.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding was received

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

local ethical committee (Instituto de Investigacion Biomedica de Malaga - IBIMA).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

No data in external datasets

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted July 16, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
CLOT STIFFNESS MEASURED BY SEER SONORHEOMETRY AS A MARKER OF POOR PROGNOSIS IN HOSPITALIZED COVID-19 PATIENTS
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
CLOT STIFFNESS MEASURED BY SEER SONORHEOMETRY AS A MARKER OF POOR PROGNOSIS IN HOSPITALIZED COVID-19 PATIENTS
Francisco José López-Jaime, Sandra Martín-Téllez, Alberto Doblas-Márquez, Ignacio Márquez-Gómez, José María Reguera-Iglesias, Manuel Isidro Muñoz-Pérez, Ihosvany Fernández-Bello, Adrián Montaño
medRxiv 2021.07.13.21260256; doi: https://doi.org/10.1101/2021.07.13.21260256
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
CLOT STIFFNESS MEASURED BY SEER SONORHEOMETRY AS A MARKER OF POOR PROGNOSIS IN HOSPITALIZED COVID-19 PATIENTS
Francisco José López-Jaime, Sandra Martín-Téllez, Alberto Doblas-Márquez, Ignacio Márquez-Gómez, José María Reguera-Iglesias, Manuel Isidro Muñoz-Pérez, Ihosvany Fernández-Bello, Adrián Montaño
medRxiv 2021.07.13.21260256; doi: https://doi.org/10.1101/2021.07.13.21260256

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (238)
  • Allergy and Immunology (519)
  • Anesthesia (124)
  • Cardiovascular Medicine (1407)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (291)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (580)
  • Epidemiology (10264)
  • Forensic Medicine (6)
  • Gastroenterology (526)
  • Genetic and Genomic Medicine (2611)
  • Geriatric Medicine (253)
  • Health Economics (495)
  • Health Informatics (1727)
  • Health Policy (788)
  • Health Systems and Quality Improvement (669)
  • Hematology (266)
  • HIV/AIDS (563)
  • Infectious Diseases (except HIV/AIDS) (12066)
  • Intensive Care and Critical Care Medicine (647)
  • Medical Education (272)
  • Medical Ethics (83)
  • Nephrology (286)
  • Neurology (2448)
  • Nursing (143)
  • Nutrition (374)
  • Obstetrics and Gynecology (486)
  • Occupational and Environmental Health (565)
  • Oncology (1314)
  • Ophthalmology (397)
  • Orthopedics (145)
  • Otolaryngology (235)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (341)
  • Pediatrics (776)
  • Pharmacology and Therapeutics (328)
  • Primary Care Research (294)
  • Psychiatry and Clinical Psychology (2390)
  • Public and Global Health (4987)
  • Radiology and Imaging (892)
  • Rehabilitation Medicine and Physical Therapy (520)
  • Respiratory Medicine (680)
  • Rheumatology (307)
  • Sexual and Reproductive Health (253)
  • Sports Medicine (244)
  • Surgery (296)
  • Toxicology (45)
  • Transplantation (140)
  • Urology (108)